You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生製藥(01530.HK)附屬三生國健與NumabTherapeutics合作開發新型腫瘤免疫多特異性抗體
格隆匯 12-12 18:02

格隆匯12月12日丨三生製藥(01530.HK)公告,內容有關公司的附屬公司三生國健藥業(上海)股份有限公司(三生國健)與NumabTherapeutics合作開發一系列腫瘤免疫新型多特異性抗體。Numab是一家位於瑞士蘇黎世區的生物製藥公司,致力於研發治療癌症的藥物。三生國健將負責選定抗體分子在中國大陸、台灣、香港和澳門的開發和商業化。

公司無法確保將能成功開發或最終上市銷售一系列新型多特異性抗體。公司股東及潛在投資者在買賣公司股份時務請審慎行事。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account